Study details
Enrolling now
Transcranial Ultrasound Stimulation (TUS) Trial
Sanmai Technologies PBC dba Sanmai
NCT IDNCT07207122ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 11 months
Ages
18–80
Locations
1 site in CA
What this study is about
This trial is testing if transcranial ultrasound stimulation can improve neurological and cognitive function in people with Alzheimer's, Parkinson's, or other neurodegenerative diseases. The treatment involves using a device to stimulate specific areas of the brain.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Transcranial focused ultrasound modulation administered to a region involved in disease pathology
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Beck Depression Inventory, GAD-7
Secondary: Beck Depression Inventory, GAD-7
Body systems
Neurology